Bristol Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-51,100
Closed -$174K 76
2018
Q3
$174K Buy
51,100
+50,000
+4,545% +$170K 0.29% 41
2018
Q2
$4K Hold
1,100
0.01% 48
2018
Q1
$4K Sell
1,100
-190,000
-99% -$691K 0.01% 24
2017
Q4
$889K Buy
191,100
+168,650
+751% +$785K 0.56% 35
2017
Q3
$251K Buy
+22,450
New +$251K 0.25% 56
2017
Q2
Hold
0
75